Building new capabilities to safeguard affordable and quality medicines for patients worldwide

When Sandoz spun off from Novartis, the company faced the immense challenge of building its R&D and data capabilities from scratch without disrupting the work of thousands of scientists delivering affordable, life-saving medicines. To tackle this, Sandoz partnered with CAS to implement CAS SciFinder^®, providing access to the world’s largest curated chemical database. Within just six weeks, CAS delivered a tailored solution with comprehensive training, enabling Sandoz to rapidly innovate, streamline workflows, and maintain seamless operations during the transition.